Frank Tamburro

Clinical and non-clinical activities as they relate to R&D are by and large the biggest categories of indirect spend for biopharma. With so many investments being made in drug development, how can procurement better support innovation and drive efficiency? This session will look at how procurement can:

-Create value in an environment where speed, trust and quality are the key currencies
-Find opportunities to drive productivity across the organization to support the science
-Collaborate internally to simplify processes to cut down cycle time --Develop an innovation marketplace to simplify the search for suppliers
-Embed information on supplier and services to share knowledge globally
-Reduce cycle time in R&D, leading to significant cost reduction